The Lab Results Are In. So Why Isn't the Patient Getting Better?
You ordered the labs, reviewed the markers and built a protocol, and still your patient isn’t responding.
This is one of the most frustrating experiences in functional medicine practice, you may even be on the right track, but not be aware of the length of time it typically takes to see a response. Or you may have royally messed up and may have started one program before the right one to start with, or underestimated or overestimated the supplement program needed. I’ve seen patients put on programs with literally 10x more product than they need and I’ve seen even more patients put on programs with a 2 capsule a day dose based on label strength for a product that requires at least 3x that to achieve any results.
After more than thirty years of clinical practice and training hundreds of functional medicine practitioners, I can tell you with confidence: in most cases, the problem isn't the accuracy of the lab report, it’s the dosing, sequencing and timing of it all.
Why GI Cases Are So Complex
GI dysfunction is among the most complex clinical territory in functional medicine. The gut is not a single system — it is a layered system of systems with interdependencies all around.
Most practitioners approach GI casework the way they learned it: identify markers, match interventions, apply supplements. It's a reasonable starting point. But it misses something foundational and is too black and white. The nuances come up with most cases where standardized protocols need to be customized to the patient and adjusted based on how the patient is responding.
When you treat what's the most dramatic finding on the lab report without addressing what's most foundational in the body, and what very likely caused the problem in the first place, then the program won’t go well or if you do get results they won’t last that long. If you have an h. Pylori case and you immediately and unsuccessfully try to treat the h. Pylori, most likely your results would have been much different if you’d spent two months preparing the person for the pathogen phase of treatment. We all want to do what seems the most urgent first and ignore or put off the underlying stabilization type programs that ultimately lead to success down the road.
This is the implementation gap I see most often — not a lack of knowledge, but a lack of design, what I call “program design” is a skill you need to learn either the hard way, by messing up over and over with real patients, or the more constructive way, by taking a class with someone that’s been doing this for a few decades and can act as a guide.
Ready to stop guessing at sequence and start designing with confidence? The KICP L1 GI Protocol Design Course open soon. Learn more and enroll →
The Three-Stage Model: How Sequence Changes Outcomes
Over decades of clinical work, I developed a staged approach to GI protocol design that consistently produces better patient outcomes not because it introduces new interventions, but because it applies them in the right order.
The model moves through three distinct stages.
Stage One: The Microbiome
Before anything else, we assess and address the foundational microbial environment. The microbiome governs immune regulation, nutrient synthesis, inflammatory signaling, and more. If you intervene at deeper levels without first establishing microbiome stability, you are working against the body's own regulatory capacity. This stage is about laying the terrain not treating it aggressively, but preparing it for what comes next. And, part of this stage includes lifestyle changes to the diet and most importantly stress reduction, to reduce GI inflammation and set the stage for what comes next.
Stage Two: GI Organ Function
Once the microbiome and lifestyle foundation is addressed, we turn to the structural and functional integrity of the GI organs themselves. This includes intestinal permeability, digestive enzyme production, stomach acid balance, and upper and lower GI organ function. These systems cannot be effectively restored if the microbial environment is still dysregulated.
Stage Three: Pathogens
Pathogen protocols are where many practitioners start — and that is precisely why so many protocols underperform. Addressing pathogens before stabilizing the microbiome, thoroughly dealing with diet and stress issues and restoring organ function can work, but the odds of success diminish significantly. When we spend a few months preparing for next steps and then reach pathogen treatment in stage three, the body is ready to respond — and patients feel the difference. It takes a lot of patience to do it this way, but the results speak for themselves.
This is the type of program design that changes outcomes. Not more and more supplements or another round of antibiotics with ever more aggressive interventions. If you sequence things well and work with the body then the body heals.
Understanding the model is the starting point. Applying it with clinical precision is the skill you learn in class through real life case studies. The KICP L1 course teaches practitioners exactly when to move between stages, how to read the signals, and how to adjust when patients aren't responding as expected. Explore the full curriculum →
What the Lab Work Is Really Telling You
Functional GI lab testing is one of the most powerful diagnostic tools available to practitioners. Used well, it provides a detailed map of the microbiome, inflammatory markers, digestive function, intestinal permeability, and pathogen burden, all in a single comprehensive panel.
But a map is only useful if you know how to read it in context.
The most common mistake I see in lab interpretation is treating individual markers in isolation. A practitioner sees an elevated marker, matches it to an intervention, and builds the protocol from there. The issue is that markers don't exist in isolation, they exist in relationship to each other, and more importantly, in relationship to which stage of dysfunction the patient is currently in.
The same marker can signal something very different depending on whether the microbiome is stable, whether organ function is compromised, or whether a pathogen is active. Reading the lab without that context produces incomplete clinical decisions — not because the practitioner lacks skill, but because the interpretive framework is missing. If you imagine your gas gauge in your car keeps reading incorrectly. Is the gauge itself broken? Is the gas tank leaking gas? Is the fuel sending unit in the tank that tells the gauge what to read broken? Any of these problems can appear as a gauge not working properly but if you fix the gauge the the tank is leaking you’re not really getting anywhere.
What a Systems-Based Lab Reading Looks Like
A systems-based approach to GI lab interpretation asks a different set of questions:
- What does the overall terrain look like before I identify specific targets?
- Are the foundational microbiome markers telling me this patient is ready for pathogen clearing?
- Where in the three-stage model does this patient's primary dysfunction sit?
- What should I address first to make the rest of the protocol more effective?
These are not complicated questions. But they require a framework — and they require practice reading real cases, not just reference ranges.
Patient Adherence Starts With Expectation Design
A well-sequenced protocol also changes something that most practitioners underestimate: patient adherence.
When patients understand what to expect — including what progress looks and feels like at each stage, and why some symptoms may shift before they improve — they stay in the process. When they don't have that context, even well-designed protocols lose patients at the critical moments.
Part of building a GI protocol that works is building the patient education that supports it. What should a patient experience in the first four weeks? What signals indicate the protocol is on track? When should you adjust, and when should you stay the course?
These are clinical questions with clinical answers — but they are also communication questions. The practitioner who can answer them clearly, at each stage of care, produces better patient outcomes not just because the protocol is better designed, but because the patient is better prepared.
This is one of the areas where thirty years of case experience creates a level of clinical confidence that no textbook can fully replicate. I've seen what happens when patients are prepared well — and I've seen what happens when they're not. The difference is significant, and it's teachable.
When Protocols Stall — And What to Do
Even well-designed, properly sequenced protocols will not work, cause side effects or stall. A patient plateaus or can even get worse. Expected progress doesn't appear. Lab markers improve but symptoms don't shift.
This is not a failure of the method. It is a sign that you need to dig even deeper and problem solve even more.
In a staged protocol approach, a stall tells you something specific about where the patient is in the healing process — whether the current stage needs more time, whether a foundational issue hasn't fully resolved, or whether a variable outside the protocol is interfering.
Knowing how to read a stall and respond to it — rather than abandoning the protocol or escalating interventions prematurely — is one of the core clinical skills in GI protocol design. It requires pattern recognition that comes from reviewing many cases over time.
This is the value of mentorship in functional medicine training. Not just learning what to do, but learning to recognize what is happening in real time — with real patients — and respond with confidence.
The KICP L1 course includes live case reviews with Dr. Kalish, where practitioners work through real GI cases and develop the pattern recognition that produces reliable outcomes. See what's included →
Key Takeaways
- GI dysfunction operates in layers. Effective GI protocol design requires treating those layers in sequence — microbiome first, GI organ function second, pathogens third.
- Lab work provides the map. A systems-based interpretive framework provides the context needed to read it accurately.
- Sequence is the most commonly overlooked factor in GI protocol design — and the most impactful one to get right.
- Patient education and expectation-setting are structural components of protocol success, not afterthoughts.
- When protocols stall, the stall is a clinical signal. Knowing how to read and respond to it is a learnable, mentorship-driven skill.
Frequently Asked Questions
Why do most GI protocols fail to produce consistent results? Most GI protocols underperform not because the interventions are wrong, but because they are applied out of sequence. Treating pathogens before stabilizing the microbiome, or addressing organ function before the foundational microbial environment is prepared, limits how effectively the body can respond. Sequence is the structural variable most commonly missing from GI protocol design.
What is the Kalish Institute’s three-stage model for GI protocol design? The three-stage model that Kalish Institute developed addresses GI dysfunction in a specific order: first the microbiome, then GI organ function, then pathogens. This sequence reflects the body's own healing logic — each stage prepares the terrain for the one that follows. Applying interventions in this order consistently produces better clinical outcomes than addressing presenting symptoms first.
How do I know when to move from one stage to the next in a GI protocol? Stage transitions are guided by clinical signals — shifts in patient symptoms, changes in lab markers, and observable indicators that the current stage has been adequately addressed. Learning to recognize and interpret these signals accurately is a skill developed through case experience and mentorship, not reference ranges alone.
What role does functional GI lab testing play in protocol design? Functional GI lab testing provides a comprehensive picture of the microbiome, digestive function, intestinal permeability, inflammation, and pathogen burden. Used within a systems-based interpretive framework, it informs which stage of the three-stage model to address first and guides clinical decisions at each step of the protocol.
How does patient adherence connect to GI protocol outcomes? Patient adherence is significantly improved when practitioners build clear expectations into the protocol from the start — including what patients should experience at each stage, how to recognize progress, and when to expect symptom shifts. Practitioners who design this communication into their programs see better patient retention and more consistent outcomes.
What is the most effective training for functional medicine GI protocol design? The most effective training combines structured curriculum with real-world clinical application — including lab interpretation, hands-on protocol design, and live case review with an experienced mentor. The KICP L1 GI Protocol Design Course is built specifically for licensed practitioners ready to develop consistent, results-driven GI protocols grounded in a proven three-stage clinical framework.
The Method Is the Path Forward
Understanding that sequence governs outcomes in GI protocol design is a meaningful clinical shift. It reframes the question from "what should I treat?" to "what should I treat first — and why?"
That reframe changes how you read labs. It changes how you design programs. It changes how you communicate with patients. And over time, it changes the consistency of results you see in practice.
What a blog post cannot give you is the clinical depth that comes from applying this framework to real cases — learning to recognize the signals, make the adjustments, and build the pattern recognition that produces reliable outcomes across a wide range of patients.
That is what the KICP L1 GI Protocol Design Course is built to do.
If the three-stage model resonates with how you think about GI cases, the next step is learning to apply it with precision. The course is designed for licensed practitioners who are ready to move from understanding functional GI concepts to confidently designing protocols that drive real patient results.
